Literature DB >> 16515653

Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles.

Rosanna Marsella1, Thierry Olivry, Sadatoshi Maeda.   

Abstract

The cellular and cytokine dynamics of reactions triggered by atopy patch testing with house dust mites were studied in six high-IgE beagles. Sites were scored and biopsied at 6, 24, 48, and 96 h, and samples were processed for histopathology, immunohistochemistry, and polymerase chain reaction (PCR). All dogs developed positive reactions at some point in time. Mean clinical scores were significantly higher than baseline at 24, 48, and 96 h. Clinically, one of six dogs had a positive reaction at 6 h; two of six reacted at 24 and 48 h, and five of six at 96 h. Histologically, superficial perivascular mononuclear and granulocytic dermatitis developed (5/6) after 6 h, and progressed in severity at 24 h (6/6). Additionally, at 48 h epidermal spongiosis, hyperplasia and pustules developed (5/6), and were marked at 96 h (6/6). At and beyond 6 h, progressive CD1c-positive epidermal Langerhans cell hyperplasia with cluster formation and dermal dendritic cell infiltration was noted. Cutaneous infiltration of CD3-positive T lymphocytes with epidermal clusters developed over time. mRNA expression for the cytokines gamma-interferon (gamma-IFN), interleukin-6 (IL-6), IL-12p35, IL-13, IL-18, and thymus and activation regulated chemokine (TARC) exhibited significant increases during the challenge compared to baseline, but there was no appreciable alteration in expression for tumour necrosis factor-alpha (TNF-alpha), IL-12p40, IL-10, regulated on activation normal T-cell expressed and secreted (RANTES), IL-5, IL-2, IL-4, and IL-8. No correlation was detected between clinical scores and cytokines. It is concluded that IL-6 plays a role in early reactions followed by an increase of TARC and IL-13, while IL-18 progressively increases in later reactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515653     DOI: 10.1111/j.1365-3164.2006.00508.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  12 in total

1.  Characterization of canine dendritic cells in healthy, atopic, and non-allergic inflamed skin.

Authors:  Meret Elisabeth Ricklin; Petra Roosje; Artur Summerfield
Journal:  J Clin Immunol       Date:  2010-07-31       Impact factor: 8.317

2.  Intradermal injection of Hsp60 induces cytokine responses in canine atopic and healthy skin.

Authors:  Annette Jassies-van der Lee; Victor Rutten; Peter van Kooten; Ruurd van der Zee; Ton Willemse
Journal:  Cell Stress Chaperones       Date:  2008-03-13       Impact factor: 3.667

3.  Altered plasma cytokines in dogs with atopic dermatitis.

Authors:  Hamutal Mazrier; Linda J Vogelnest; Rosanne M Taylor; Peter Williamson
Journal:  Vet Dermatol       Date:  2021-11-24       Impact factor: 1.867

4.  Gene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinae.

Authors:  Paz Schamber; Rachel Schwab-Richards; Stefan Bauersachs; Ralf S Mueller
Journal:  G3 (Bethesda)       Date:  2014-08-05       Impact factor: 3.154

5.  Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis.

Authors:  Alicja Majewska; Małgorzata Gajewska; Kourou Dembele; Henryk Maciejewski; Adam Prostek; Michał Jank
Journal:  BMC Vet Res       Date:  2016-08-23       Impact factor: 2.741

Review 6.  Translational Animal Models of Atopic Dermatitis for Preclinical Studies.

Authors:  Britta C Martel; Paola Lovato; Wolfgang Bäumer; Thierry Olivry
Journal:  Yale J Biol Med       Date:  2017-09-25

7.  Serum canine thymus and activation-regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis.

Authors:  Ryota Asahina; Kazunori Ueda; Yuri Oshima; Toshitaka Kanei; Masahiro Kato; Masutaka Furue; Toshihiro Tsukui; Masahiko Nagata; Sadatoshi Maeda
Journal:  Vet Dermatol       Date:  2020-09-17       Impact factor: 1.589

8.  Expression of barrier proteins in the skin lesions and inflammatory cytokines in peripheral blood mononuclear cells of atopic dogs.

Authors:  Sarita Kanwal; Shanker K Singh; Sandeep P Soman; Soumen Choudhury; Priyambada Kumari; Pradeep K Ram; Satish K Garg
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

9.  Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.

Authors:  A J Gonzales; J W Bowman; G J Fici; M Zhang; D W Mann; M Mitton-Fry
Journal:  J Vet Pharmacol Ther       Date:  2014-02-05       Impact factor: 1.786

Review 10.  Companion Animals as Models for Inhibition of STAT3 and STAT5.

Authors:  Matthias Kieslinger; Alexander Swoboda; Nina Kramer; Barbara Pratscher; Birgitt Wolfesberger; Iwan A Burgener
Journal:  Cancers (Basel)       Date:  2019-12-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.